Related references
Note: Only part of the references are listed.Two-Component Systems of S. aureus: Signaling and Sensing Mechanisms
Lisa Bleul et al.
GENES (2022)
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Beata Mlynarczyk-Bonikowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study
Yu Ri Kang et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2022)
Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus
Adrianna M. Turner et al.
FRONTIERS IN MICROBIOLOGY (2021)
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
Aref Shariati et al.
SCIENTIFIC REPORTS (2020)
Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections Among 122 Hospitals
Jennifer S. McDanel et al.
CLINICAL INFECTIOUS DISEASES (2015)
Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
Jian Hu et al.
PLOS ONE (2013)
Mutational Analyses of Open Reading Frames within the vraSR Operon and Their Roles in the Cell Wall Stress Response of Staphylococcus aureus
N. McCallum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical isolate
V. C. Doddangoudar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
Benjamin P. Howden et al.
PLOS PATHOGENS (2011)
An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Longzhu Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Bloodstream Infections and Clinical Significance of Healthcare-associated Bacteremia: A Multicenter Surveillance Study in Korean Hospitals
Jun Seong Son et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Development of Reduced Vancomycin Susceptibility in Methicillin-Susceptible Staphylococcus aureus
Satish K. Pillai et al.
CLINICAL INFECTIOUS DISEASES (2009)
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus
MC Enright et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)
Share Paper
